Publication | Closed Access
A phosphoramidate‐based prostate‐specific membrane antigen‐targeted SPECT agent
43
Citations
33
References
2011
Year
While DTPA may not represent the ideal chelate structure for 99mTc(CO)3, the data provides proof-of-concept support for the development of a next-generation phosphoramidate-based PSMA inhibitor-conjugates for use as SPECT imaging agents.
| Year | Citations | |
|---|---|---|
Page 1
Page 1